99 related articles for article (PubMed ID: 26970060)
1. Ulcerations on abdominal wound scar associated with aflibercept therapy.
Rivas-Tolosa N; Calomarde L; Bancalari B; Guillén C; Sanmartín O
J Dermatol; 2016 Sep; 43(9):1095-6. PubMed ID: 26970060
[No Abstract] [Full Text] [Related]
2. Comparing aflibercept, bevacizumab, and ranibizumab for DME: analysis of DRCR Protocol T.
Wykoff CC; Hariprasad SM
Ophthalmic Surg Lasers Imaging Retina; 2015 Mar; 46(3):302-5. PubMed ID: 25835307
[No Abstract] [Full Text] [Related]
3. Medication-related osteonecrosis of the jaw associated with aflibercept.
Zarringhalam P; Brizman E; Shakib K
Br J Oral Maxillofac Surg; 2017 Apr; 55(3):314-315. PubMed ID: 27923511
[No Abstract] [Full Text] [Related]
4. Retinal pigment epithelial tear after intravitreal aflibercept for neovascular age-related macular degeneration.
Sato T; Ooto S; Suzuki M; Spaide RF
Ophthalmic Surg Lasers Imaging Retina; 2015 Jan; 46(1):87-90. PubMed ID: 25559517
[TBL] [Abstract][Full Text] [Related]
5. Aflibercept anti-vascular endothelial growth factor therapy in vitrectomized eyes with neovascular age-related macular degeneration.
Jung JJ; Hoang QV; Arain MZ; Chang S
Acta Ophthalmol; 2016 May; 94(3):e249-50. PubMed ID: 26401896
[No Abstract] [Full Text] [Related]
6. Ziv-aflibercept (Zaltrap) for metastatic colorectal cancer.
Med Lett Drugs Ther; 2013 Apr; 55(1415):e36. PubMed ID: 23836346
[No Abstract] [Full Text] [Related]
7. Acneiform eruption during therapy with aflibercept for metastatic colorectal carcinoma.
Martínez-Doménech A; García-Legaz Martínez M; Magdaleno-Tapial J; Valenzuela-Oñate C; Pérez-Pastor G; Alegre-de Miquel V; Pérez-Ferriols A
Australas J Dermatol; 2020 Feb; 61(1):e107-e108. PubMed ID: 31332772
[No Abstract] [Full Text] [Related]
8. Three-month outcomes of ziv-aflibercept in the treatment of diabetic macular oedema.
Ashraf M; Souka AA; El Kayal H; El Manhaly M; Abdallah MH
Acta Ophthalmol; 2016 Nov; 94(7):e669. PubMed ID: 27227354
[No Abstract] [Full Text] [Related]
9. Frequency and characteristics of intraocular inflammation after aflibercept injection.
Fine HF; Roth DB; Shah SP; Haque T; Wheatley HM
Retina; 2015 Apr; 35(4):681-6. PubMed ID: 25394166
[TBL] [Abstract][Full Text] [Related]
10. Is there a benefit from addiction to anti-VEGF therapy in patients with colorectal cancer?
Saif MW
Anticancer Res; 2013 Jun; 33(6):2377-80. PubMed ID: 23749885
[TBL] [Abstract][Full Text] [Related]
11. Treat and extend regimen with aflibercept for choroidal neovascularization in angioid streaks.
Diago T
Eye (Lond); 2016 Apr; 30(4):637-9. PubMed ID: 26795418
[No Abstract] [Full Text] [Related]
12. Preservation of macular structure and function after intravitreal aflibercept for choroidal neovascularization associated with serpiginous choroiditis.
Schatz P; Skarin A; Lavaque AJ; Lima LH; Arevalo JF
Acta Ophthalmol; 2016 Dec; 94(8):839-841. PubMed ID: 26780597
[No Abstract] [Full Text] [Related]
13. Targeted therapy for metastatic colorectal cancer: role of aflibercept.
Mitchell EP
Clin Colorectal Cancer; 2013 Jun; 12(2):73-85. PubMed ID: 23102896
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and adverse events of aflibercept, ranibizumab and bevacizumab in age-related macular degeneration: a trade-off analysis.
Schmid MK; Bachmann LM; Fäs L; Kessels AG; Job OM; Thiel MA
Br J Ophthalmol; 2015 Feb; 99(2):141-6. PubMed ID: 25271911
[TBL] [Abstract][Full Text] [Related]
15. An oncology nurses' guide to new targeted agents for metastatic colorectal cancer.
McIntyre K
Clin J Oncol Nurs; 2015 Oct; 19(5):571-9. PubMed ID: 26414575
[TBL] [Abstract][Full Text] [Related]
16. Switching anti-vascular endothelial growth factor therapy for neovascular age-related macular degeneration.
Schachat AP
Am J Ophthalmol; 2013 Jul; 156(1):1-2.e1. PubMed ID: 23791369
[No Abstract] [Full Text] [Related]
17. [Aflibercept (Zaltrap(®)) approved in metastatic colorectal cancer].
André T; Chibaudel B
Bull Cancer; 2013 Oct; 100(10):1023-5. PubMed ID: 24047539
[TBL] [Abstract][Full Text] [Related]
18. [Opinion DGVS the IQWiG report for early benefit assessment of aflibercept for the treatment of metastatic colorectal cancer according to § 35a SGB V on May 29, 2013].
Z Gastroenterol; 2013 Aug; 51(8):1019-22. PubMed ID: 24298632
[No Abstract] [Full Text] [Related]
19. Intravitreal Aflibercept for Neovascular AMD: Short-Term Clinical Effects of Intravitreal Aflibercept Injection as a Predictor of Long-Term Results.
Liu EM; Shah G; Blinder KJ; Smith BT; Thomas MA
Ophthalmic Surg Lasers Imaging Retina; 2015; 46(10):1021-7. PubMed ID: 26599244
[TBL] [Abstract][Full Text] [Related]
20. Population pharmacokinetic analysis of free and bound aflibercept in patients with advanced solid tumors.
Thai HT; Veyrat-Follet C; Mentré F; Comets E
Cancer Chemother Pharmacol; 2013 Jul; 72(1):167-80. PubMed ID: 23673444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
